2022
DOI: 10.3389/fphar.2022.1045976
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced tumor penetration for efficient chemotherapy by a magnetothermally sensitive micelle combined with magnetic targeting and magnetic hyperthermia

Abstract: The high accumulation and poor penetration of nanocarriers in tumor is a contradiction of nanomedicine, which reduces the efficacy of chemotherapy. Due to the positive effect of hyperthermia on in vivo drug diffusion, we designed a magnetothermally sensitive micelle (MTM) by integrating magnetic targeting (MT), magnetic hyperthermia (MH), and magnetothermally responsive drug release to facilitate simultaneous drug accumulation and penetration in tumor. Accordingly, we synthesized a cyanine7-modified thermosens… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 53 publications
(63 reference statements)
0
2
0
Order By: Relevance
“…Lipid-based nanocarriers are among the most promising systems for this purpose because of their high biocompatibility, ability to overcome the BBB, improved encapsulation capacity, and the possibility to modify their surface to improve tumor targeting; , moreover, these systems can be designed to release their cargo when exposed to a specific stimulus (e.g., pH, enzymes, temperature). As a consequence, various multimodal approaches to antitumor drug delivery have been explored, combining conventional therapeutic strategies ( e.g., chemotherapy) with other emerging alternatives such as magnetic hyperthermia (MH), photothermal therapy (PTT), and gene therapy. Among them, MH is a promising strategy to develop a minimally invasive, localized, and remote antitumor treatment. Conversely to conventional pharmacological agents used for cancer treatment or other methods of whole-body or regional hyperthermia, the heating in MH remains highly localized, and it depends on the simultaneous presence of magnetic nanoparticles and their excitation under an external alternating magnetic field (AMF) . This contributes to minimize systemic side effects and allows for a better recovery of the neighboring healthy cells or tissues, since the microenvironment of the treated area is not strongly stressed. , …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Lipid-based nanocarriers are among the most promising systems for this purpose because of their high biocompatibility, ability to overcome the BBB, improved encapsulation capacity, and the possibility to modify their surface to improve tumor targeting; , moreover, these systems can be designed to release their cargo when exposed to a specific stimulus (e.g., pH, enzymes, temperature). As a consequence, various multimodal approaches to antitumor drug delivery have been explored, combining conventional therapeutic strategies ( e.g., chemotherapy) with other emerging alternatives such as magnetic hyperthermia (MH), photothermal therapy (PTT), and gene therapy. Among them, MH is a promising strategy to develop a minimally invasive, localized, and remote antitumor treatment. Conversely to conventional pharmacological agents used for cancer treatment or other methods of whole-body or regional hyperthermia, the heating in MH remains highly localized, and it depends on the simultaneous presence of magnetic nanoparticles and their excitation under an external alternating magnetic field (AMF) . This contributes to minimize systemic side effects and allows for a better recovery of the neighboring healthy cells or tissues, since the microenvironment of the treated area is not strongly stressed. , …”
Section: Introductionmentioning
confidence: 99%
“…As a consequence, various multimodal approaches to antitumor drug delivery have been explored, combining conventional therapeutic strategies ( e.g., chemotherapy) with other emerging alternatives such as magnetic hyperthermia (MH), photothermal therapy (PTT), and gene therapy. 17 20 Among them, MH is a promising strategy to develop a minimally invasive, localized, and remote antitumor treatment. 21 23 Conversely to conventional pharmacological agents used for cancer treatment or other methods of whole-body or regional hyperthermia, the heating in MH remains highly localized, and it depends on the simultaneous presence of magnetic nanoparticles and their excitation under an external alternating magnetic field (AMF).…”
Section: Introductionmentioning
confidence: 99%